Clinical Science  |   July 2006
Splanchnic Oxygen Consumption Is Impaired during Severe Acute Normovolemic Anemia in Anesthetized Humans
Author Affiliations & Notes
  • Mali Mathru, M.D.
  • Daneshvari R. Solanki, F.R.C.A.
  • Lee C. Woodson, M.D., Ph.D.
  • J Sean Funston, M.D.
  • Orthan Ozkan, M.D.
  • Sheryl N. Henkel, R.N.
  • Deli Wang, M.D., Ph.D.
  • Dennis Gore, M.D.
  • Donald S. Prough, M.D.
  • * Professor, Department of Anesthesiology, # Research Assistant Professor, Biostatistics and Bioinformatics Unit, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama. † Professor, ‡ Associate Professor, ∥ Research Coordinator, Department of Anesthesiology, § Assistant Professor, Department of Radiology, ** Professor, Department of Surgery, University of Texas Medical Branch.
Article Information
Clinical Science / Cardiovascular Anesthesia / Endocrine and Metabolic Systems / Hematologic System / Neurosurgical Anesthesia / Respiratory System
Clinical Science   |   July 2006
Splanchnic Oxygen Consumption Is Impaired during Severe Acute Normovolemic Anemia in Anesthetized Humans
Anesthesiology 7 2006, Vol.105, 37-44. doi:
Anesthesiology 7 2006, Vol.105, 37-44. doi:
A RESTRICTIVE approach to administering blood products has evolved in recent years, motivated by pressure to conserve a limited blood supply and avoid adverse effects of transfusion.1,2 This approach, combined with aggressive fluid resuscitation, often leads to acute normovolemic anemia (ANA) in the perioperative period.3 The safety of ANA is based on the premise that, as arterial oxygen content decreases, tissues maintain oxygen consumption by compensatory mechanisms that include increases in cardiac output, oxygen extraction ratio, and regional blood flow.4–6 When whole body oxygen delivery (Do2) decreases below a critical point, compensatory mechanisms become insufficient. At that point, oxygen consumption becomes supply dependent and decreases as Do2decreases.7 
The critical point during ANA at which oxygen consumption becomes supply dependent can be expressed as a critical Do2or critical hematocrit.7,8 To date, systematic prospective efforts to determine the critical Do2in conscious, healthy humans have failed, despite reducing hemoglobin concentration to 5 g/dl and further reducing cardiac output by infusion of β-adrenergic antagonists.9,10 The data in anesthetized humans are limited to one case report.11 However, studies that demonstrate preservation of systemic oxygen consumption during ANA have not examined regional supply dependency. Specifically, they have not examined the physiologic effects of ANA on splanchnic oxygen consumption and Do2. Splanchnic oxygen consumption and Do2may be influenced by various factors, such as redistribution of cardiac output to organs such as the heart and brain. If preservation of those organ systems occurs at the expense of the splanchnic vascular bed, splanchnic integrity could be compromised.12–15 Heterogeneity of oxygen supply and demand exists between organs as well as within individual organs; this heterogeneity is further exacerbated during states of reduced oxygen delivery.13 Furthermore, reduction in splanchnic perfusion associated with anesthesia, increases in splanchnic oxygen consumption associated with surgical trauma, and diminished perioperative oxygen extraction capabilities may also interfere with the ability of the splanchnic regions to adapt to reduced regional Do2associated with ANA.15–17 
Therefore, the risk to the gastrointestinal system may be underestimated during ANA. As a consequence, recommendations regarding hematocrit levels below which transfusion is indicated may be associated with inadequate regional Do2. This implies that organ-specific regional measurements should be made to determine the sufficiency of oxygen in splanchnic organs. Knowledge of regional Do2and oxygen consumption is important to anesthesiologists and surgeons because more than 50% of erythrocyte transfusions occur in the operating room.18 To test the validity of our hypothesis that, during ANA and diminished Do2, splanchnic and preportal oxygen consumption would be impaired despite preservation of systemic oxygen consumption, we produced ANA in patients undergoing anesthesia and surgery.
Our overall goal was to characterize systemic, splanchnic, preportal oxygen consumption and Do2responses in anesthetized humans subjected to severe ANA. We accomplished this goal in anesthetized patients undergoing spine and abdominal surgery. To exclude the effects of surgical trauma on splanchnic oxygen consumption, we chose spine surgery patients in whom ANA was performed before surgery. In a group of patients undergoing abdominal surgery, we directly measured portal blood flow to study the effects of ANA on Do2to splanchnic organs, excluding the liver. This group also facilitated quantification of the effects of superimposed surgical trauma on splanchnic oxygen consumption during ANA.
Materials and Methods
The study was approved by the Institutional Review Board of the University of Texas Medical Branch in Galveston, Texas. Written informed consent was obtained from each patient. Twelve patients (10 men and 2 women) undergoing spine surgery and 7 patients (5 men and 2 women) undergoing abdominal surgery were included in the study. Preoperative diagnoses of patients undergoing abdominal surgery included nonmetastatic, medium- to well-differentiated gastric adenocarcinoma (n = 4), and highly differentiated pancreatic neoplasm (n = 3). Criteria for inclusion in the study were a baseline hemoglobin concentration of 12 g/dl or greater and absence of comorbid medical conditions, including coronary artery disease, congestive heart failure, unstable angina, hemodynamically significant valvular heart disease, diabetes mellitus, uncontrolled hypertension, hepatobiliary disease, and renal dysfunction. Hepatic failure was defined as total bilirubin concentration more than two times the upper normal range, and renal dysfunction was defined as serum creatinine concentration greater than 1.3 mg/dl.
Patients were premedicated with 0.5 mg lorazepam orally 1 h before arrival in the operating room. A 16-gauge intravenous catheter was placed for fluid infusion. Routine monitors, i.e.  , blood pressure cuff, electrocardiogram (lead V5), and pulse oximeter probes, were applied in the operating room. General anesthesia was induced with sodium thiopental (3 mg/kg), with the trachea intubated after administration of cisatracurium (0.15 mg/kg). Patients were then mechanically ventilated (Servo 900C; Siemens AB, Solna, Sweden) with an inspired gas mixture of oxygen–nitrous oxide (50:50). The ventilator rate was adjusted to maintain normocapnia. Anesthesia was maintained with 0.5–1% (end-tidal) isoflurane and intermittent fentanyl boluses (50–100 μg). The left radial artery was cannulated with a 20-gauge catheter to monitor blood pressure and obtain arterial blood samples. A pulmonary arterial catheter was inserted percutaneously via  the left internal jugular vein after induction of anesthesia. The catheter was used for blood sampling and to monitor pulmonary arterial pressures, cardiac filling pressures, and cardiac output. The hepatic vein was cannulated via  the right internal jugular vein, and a preformed side-vented catheter was positioned in the hepatic vein. The deep but nonwedged position of the catheter was verified by an interventional radiologist using fluoroscopy with a small amount of contrast dye. Hepatic vein blood samples were used to measure ketone bodies and splanchnic blood flow. Splanchnic blood flow was estimated by a primed (12 mg) and continuous (1 mg/min) intravenous infusion of indocyanine green (Cardiogreen; Becton-Dickinson, Franklin Lakes, NJ).19,20 The blood samples were centrifuged, and indocyanine green extraction concentrations were determined spectrophotometrically using a wavelength of 805 nm. The blood concentrations were derived from a calibration curve; the coefficient of variation (SD/mean) of the indocyanine green extraction analysis was 0.7% (n = 12). Splanchnic blood flow was then derived from the dye infusion rate and the arterial–hepatic venous dye concentration difference.20 The mean (± SD) hepatic indocyanine green extraction ratio ([arterial indocyanine green concentration − hepatic venous indocyanine green concentration]/arterial indocyanine green concentration) was 28 ± 12%.
We measured portal blood flow in seven patients undergoing abdominal surgery. After upper midline laparotomy, the portal vein distal to the gastroduodenal artery was isolated, and a dual-channel ultrasound transit-time flowmeter (Transonic Systems, Inc., Ithaca, NY) was connected to the portal venous (diameter 16–18 mm) probe to record blood flows continuously.
Induction of Acute Normovolemic Anemia
After induction of anesthesia, blood was withdrawn from a peripheral vein and was simultaneously replaced with an equal volume of a 5% albumin solution to reach a target hemoglobin concentration of 6.0 g/dl or less and to maintain cardiac filling pressures. The amount of blood to be withdrawn was estimated from the relation proposed by Gross et al.  21 The method for producing ANA has been described previously.4,9 Briefly, 500-ml aliquots of blood were removed through a large-bore peripheral intravenous cannula into CPDA-1 collection bags (Baxter Healthcare, Deerfield, IL). Removal of each 500 ml of blood required approximately 20 min. Isovolemia was maintained by holding pulmonary arterial occlusion pressure constant by intravenous infusion of 5% albumin solution or the subject’s own platelet-rich plasma (after separation by centrifugation from the erythrocytes of the removed blood) simultaneously with blood removal, in quantities slightly greater (by 15 ± 7%, mean ± SD) than that of the removed blood, to compensate for the extravascular distribution of albumin.22 
All measurements were performed before surgery in the spine surgery group and during the initial phase of the operation in the abdominal surgery group. Thirty minutes after induction of anesthesia, baseline regional hemodynamic measurements were made with the patients receiving an inspired gas mixture containing oxygen–nitrous oxide (50:50) and 1% isoflurane. Lead V5 of the electrocardiogram was closely monitored for evidence of ischemia throughout the study period. Cardiac output was measured with thermodilution in triplicate, and the mean value was used for calculations. Hemoglobin concentration oxygen saturations were measured using a CO-Oximeter (IL 282; Instrumentation Laboratories, Lexington, MA). Arterial oxygen content was calculated as 1.39 · hemoglobin concentration · arterial oxygen saturation + dissolved oxygen. Systemic Do2was measured as the product of cardiac output or regional flow and arterial oxygen content. Systemic oxygen consumption was measured from inspired and expired gases by open circuit indirect calorimetry (DeltaTrac; Sensor Medics, Inc., Anaheim, CA). Splanchnic oxygen delivery (ml · min−1· m−2) was calculated as the product of splanchnic blood flow and arterial oxygen content. Splanchnic oxygen consumption was calculated as splanchnic blood flow multiplied by the difference between arterial and hepatic venous oxygen content. Preportal oxygen delivery (ml · min−1· m−2) was estimated as the product of portal venous oxygen content and blood flow. Preportal oxygen consumption (ml · min−1· m−2) was calculated as portal blood flow multiplied by the difference between arterial and portal venous oxygen content.23 Oxygen extraction was derived from oxygen consumption/Do2. Lactate concentrations were measured enzymatically (YSI No 2700; Yellow Springs Instrument Company, Yellow Springs, OH).
Regional Stable Isotope Analysis of Lactate Kinetics
A primed and continuous infusion (prime = 8 μmol/kg; infusion rate = 0.56 μmol · kg−1· min−1) of lactate containing the stable isotope 13C was used to estimate exchange, production, and lactate oxidation.24 This method is based on the measurement of pyruvate and lactate enrichment and concentrations in arterial and venous blood and the rate of blood flow through the splanchnic bed. The net balance of lactate across the splanchnic bed (NB) was calculated by multiplying the difference between arterial and venous lactate concentration by hepatic blood flow using the formula
where Ca and Cv are the arterial and venous lactate concentrations, respectively, and hBF is hepatic blood flow.24 
The rate of uptake of lactate across the splanchnic bed (denoted Rd) was calculated by dividing the net uptake of tracer by the arterial lactate enrichment, using the formula
where Ea and Ev are the values for arterial and hepatic venous lactate enrichment, respectively.
The rate of release of lactate from the splanchnic bed (Ra) was calculated from the difference between the rate of uptake and the net balance of unlabeled lactate across the splanchnic bed:
Clearance of lactate by the splanchnic bed was calculated by dividing Rd by the arterial concentration:
Stable isotopic enrichment of plasma glucose, pyruvate, lactate and alanine were determined by quadrupole chromatography–mass spectrometry (5985-B gas chromatograph–mass spectrometer; Hewlett Packard, Palo Alto, CA). Plasma concentrations of glucose and lactate were determined by an autoanalyzer (YSI Lactate and Glucose Analyzer; Yellow Springs Instruments, Columbus, OH).
Statistical Analysis
Data obtained at the end of hemodilution were compared with data obtained at baseline. Patient characteristics data were described in terms of means and SDs. A Student t  test was used to detect changes in splanchnic and preportal flow, Do2, oxygen consumption and oxygen extraction ratio between baseline, and target hemoglobin concentration. These comparisons were conducted in the spine and abdominal surgery groups, respectively. To assure that the distributions of changes for each variable were normal, we used the Shapiro-Wilks normality test. All P  values are two tailed, and statistical significance was accepted as P  < 0.05. Results are presented as mean values ± SDs.
Patient characteristics are listed in table 1. To reach the target hemoglobin level, the exchanged volume was 2,375 ± 155 in both groups. Time to perform hemodilution was 52 ± 15 min in the spine surgery group and 48 ± 10 min in the abdominal surgery group. None of the patients in the spine surgery group required any vasopressors to maintain mean arterial pressure. However, one patient in the abdominal surgery group required 5 mg ephedrine to maintain mean arterial pressure. The last dose of ephedrine was administered 50 min before the hemodynamic measurements after ANA had been induced. The total duration of the experiment was 3.5 ± 0.3 h.
Table 1. Patient Characteristics 
Image not available
Table 1. Patient Characteristics 
Systemic Responses to Acute Normovolemic Anemia
Decreases in hemoglobin concentration from 13.6 ± 1.2 g/dl to 5.9 ± 0.3 g/dl in the spine surgery group and from 13.3 ± 0.5 g/dl to 5.7 ± 0.3 g/dl in the abdominal surgery group increased the cardiac index without significantly changing heart rate (table 2). When the target hemoglobin concentration was reached, the increased cardiac index did not compensate for the decreased arterial oxygen content, i.e.  , systemic Do2significantly decreased (P  < 0.05 for spine surgery group and P  < 0.05 for abdominal surgery group; table 2). In contrast to decreased Do2, systemic oxygen consumption and oxygen extraction increased at the target hemoglobin concentration (5.9 ± 0.3) in the spine surgery group (P  < 0.05 for oxygen consumption and P  < 0.05 for oxygen extraction) during ANA. Parallel changes in oxygen consumption and oxygen extraction were observed in abdominal surgery group (P  < 0.05 for oxygen consumption and P  < 0.05 for oxygen extraction). Despite successfully reducing the hemoglobin concentration to 5.9 during ANA, systemic oxygenation was preserved as assessed by two primary measures: Oxygen consumption did not decrease, and there were only clinically insignificant increases in plasma lactate concentration (table 2).
Table 2. Systemic Response of ANA in Spine (n = 12) and Abdominal (n = 7) Surgery Groups of Patients 
Image not available
Table 2. Systemic Response of ANA in Spine (n = 12) and Abdominal (n = 7) Surgery Groups of Patients 
Splanchnic and Preportal Measurements in Spine and Abdominal Surgery Patients
Compared with baseline, the level of splanchnic Do2during ANA significantly decreased by 65.2 ± 3.6 ml · min−1· m−2(P  < 0.05; table 3). Both splanchnic oxygen consumption and splanchnic flow during ANA decreased significantly compared with baseline levels. The mean decrease in oxygen consumption was 20.9 ± 5.7 ml · min−1· m−2(P  < 0.05). The mean decrease for splanchnic flow was 0.3 ± 0.02 l · min−1· m−2(P  < 0.05). The splanchnic oxygen extraction ratio increased compared with baseline by a mean of 0.14 ± 0.03 (P  < 0.05; table 3).
Table 3. Hepatosplanchnic and Preportal Flow, Do2, and O2ER in Patients Undergoing Spine and Abdominal Surgery 
Image not available
Table 3. Hepatosplanchnic and Preportal Flow, Do2, and O2ER in Patients Undergoing Spine and Abdominal Surgery 
Except for the preportal oxygen extraction level, which increased at target hemoglobin concentration compared with baseline levels, the other three variables decreased at the target hemoglobin concentration level (table 3).
Ketone Body Ratio and Lactate Kinetics in Spine Surgery Patients
At the target hemoglobin concentration, the mean ketone body ratio increased significantly from baseline by a mean of 1.16 ± 0.12 (P  < 0.05; table 4). The net balance of unlabeled lactate decreased from a baseline value of 557 ± 27 to 347 ± 37 (P  < 0.05) during ANA.
Table 4. Biochemical Markers of Anaerobic Metabolism in Hepatosplanchnic Vascular Bed Spine Surgery Patients (n = 12) 
Image not available
Table 4. Biochemical Markers of Anaerobic Metabolism in Hepatosplanchnic Vascular Bed Spine Surgery Patients (n = 12) 
Mean hepatic 13C lactate uptake for patients at the target hemoglobin concentration increased significantly (216 ± 29.7 μmol/min) from baseline levels (P  < 0.05) (table 4). The mean hepatic 13C lactate release from the splanchnic bed at the target hemoglobin concentration during ANA was significantly increased by 140 ± 36.1 μmol/min from baseline (P  < 0.05).
The most important finding of this study is that reducing hemoglobin concentration to 5.93 g/dl (hematocrit 17.79%) in anesthetized humans resulted in inadequate oxygenation in splanchnic organs as assessed by our two primary measures: (1) reduction in splanchnic and portal oxygen consumption and (2) regional (hepatic vein) increases in surrogate markers of anaerobic metabolism, i.e.  , increased regional generation of lactate and an increased β-hydroxybutyrate–to–acetoacetate (βOHB/AcAc) ratio. Importantly, at the same level of ANA, systemic oxygen consumption was preserved.
Despite its critical importance, the response of splanchnic organs to ANA in humans has never been investigated. Therefore, we could compare our findings only to previous studies in pigs, which have similar cardiovascular and digestive systems to those in humans.25 Experimental studies in anesthetized pigs demonstrated a two-phase response, consisting of preserved splanchnic oxygenation during mild ANA (hematocrit 14%) and progressive impairment during severe ANA (hematocrit 6%).26–29 
Possible reasons for the apparently greater tolerance of pigs for ANA include interspecies differences, depth of anesthesia, and the beneficial redistribution of blood flow, in favor of the mucosal layer, the dominant oxygen consuming part within the intestinal wall.28,29 Moreover, in comparison to humans, pigs have a lower normal range of hemoglobin (8–9 g/dl), and the methodology used to measure regional blood flow could have also played a role in this differential response.27 Anesthesia reduces splanchnic blood flow and increases splanchnic oxygen extraction.16,26 One critical adaptive mechanism during ANA is the redistribution of cardiac output toward the heart and brain at the expense of organs perfused by the splanchnic vascular bed.12,14 The reduction in splanchnic and portal blood flow during ANA influenced by preoperative medications must be entertained (i.e.  , metoprolol).30,31 Fortunately, it is unlikely that our results were modified by the β-blocker therapy, because it has been recently demonstrated that metoprolol in comparison with propanolol does not significantly reduce hepatic flow in patients with cirrhosis.32 Therefore, the observed reductions in splanchnic and portal blood flow in the current study might be related to central sympathetic stimulation related to inadequate levels of anesthesia.
In experimental models, an oxygen supply–dependent state demonstrates decreased adenosine triphosphatase flux (oxygen consumption) in the liver. This was accompanied by increases in inorganic phosphate/adenosine triphosphatase (measured by nuclear magnetic resonance spectroscopy) and hepatic venous βOHB/AcAc.33,34 In our patients, when the target level of hemoglobin concentration (5.9 g/dl) was reached during ANA, a reduction in splanchnic oxygen consumption was accompanied by increases in βOHB/AcAc, suggesting regional dysoxia (oxygen consumption exceeds the ability of Do2to provide oxygen consumption) and anaerobic metabolism.
Despite the occurrence of oxygen supply dependency in the splanchnic bed in our patients, the net balance of unlabeled lactate across the splanchnic region remained steady (positive) at baseline (557 ± 27 μmol/min) and during ANA (347 ± 37 μmol/min). Our data again reiterate the limitation of balance studies using (arterial-venous) difference of lactate across splanchnic organs.24,35 Without knowing the total rate of lactate production by the entire body, lactate balance across a perfused bed or organ does not reveal the relative contribution of that bed or organ to lactate production. Also, the net balance of lactate does not allow separate estimation of lactate production and utilization. Finally, balance studies cannot determine whether the origin of the lactate is glycolysis or other nonglucose sources.36 To overcome these limitations, we used the novel stable isotope tracer methodology to estimate exchange, production, and lactate oxidation. The calculated lactate kinetics across the total splanchnic circulation revealed a baseline splanchnic release of lactate 358 ± 67.7 before ANA, which increased by 50% to 498 ± 90.7 after ANA. This was accompanied by compensatory increase in hepatic uptake from 434 ± 21.4 to 649 ± 38.6 μmol with maintained splanchnic uptake as evidenced by the post-ANA arterial lactate levels of 1.07 ± 0.13 remaining within normal limits (< 2.2 mm). Although lactate may not always be a reliable indicator of limitations in oxygen availability, this rebalancing of lactate flux suggests that net anaerobic metabolism was occurring in the gut, and oxygen consumption supply dependency was occurring relatively early. However, the clinical importance of temporary splanchnic lactate production is unknown.
As in previous studies in conscious humans, in the current study, we did not define in anesthetized patients a critical level of systemic Do2below which oxygen consumption declined, even though splanchnic and preportal oxygen consumption was impaired at the same level of ANA.9,10 This suggests that systemic Do2and oxygen consumption indices are not sufficiently sensitive to detect organ system dysfunction or regional dysoxia, especially in splanchnic organs.7,8,13,37 Unlike in conscious humans, the levels of systemic Do2and oxygen consumption were lower in our anesthetized subjects, which could be attributed to the effects of anesthetic drugs on the autonomic and cardiovascular system.38,39 Anesthetic drugs, when combined with neuromuscular blockade and mechanical ventilation, reduce myocardial muscle and brain and whole body oxygen consumption in dose-dependent fashion.40,41 This in turn might reduce critical Do2(the value of oxygen delivery below which oxygen consumption becomes supply dependent). However, contrary to previous studies, in our anesthetized patients, we observed a significant increase in systemic oxygen consumption and increased oxygen extraction. Our findings of increased systemic oxygen consumption and oxygen extraction could be attributable to light depth of anesthesia and sympathetic stimulation. Because anesthesia blunts the cardiac output response during ANA, higher critical hemoglobin levels have also been recently demonstrated at more profound anesthetic depths despite a progressive reduction in oxygen demand during anesthesia.42 There are also experimental data that demonstrate an increase in critical Do2during anesthesia, related to reduction in tissue oxygen extraction capabilities.17 The systemic response associated with ANA in this study could have been influenced by preoperative medications, i.e.  , β blockers. However, a study by Spahn et al.  43 demonstrate that chronic β blockade did not blunt the cardiac output and oxygen extraction responses to ANA in anesthetized patients.
This study does have some important strengths and limitations. Among the strengths are the ability to measure total splanchnic and portal blood flow and to estimate respective splanchnic and portal Do2and oxygen consumption during ANA in anesthetized humans. None of these indices have been previously documented in humans during ANA. The novel aspect of this study is the inclusion of surrogate markers of anaerobic metabolism, i.e.  , regional lactate synthesis and increased βOHB/AcAc ratio during supply dependency at the target levels of hemodilution.24,33,34 
Foremost among the limitations is that we were not able to determine a critical Do2for splanchnic organs in individual patients, as has been accomplished previously in animal models by using a linear regression technique to analyze the plot of oxygen consumption and Do2.37 However, such techniques are not feasible in clinical studies. We measured systemic oxygen consumption by indirect calorimetry, whereas splanchnic and preportal tissue oxygen consumption was estimated by using the Fick equation. This method has been criticized because of the potential problem of mathematical coupling.23,44 However, it has been stated that the effects of coupled errors are limited by keeping the range of independent variables as large as possible (as in our study population).23 We could also be criticized for producing such a profound hemodilution (6 g/dl hemoglobin) in view of the adverse effects of such a procedure on cognitive function.45 To minimize such a risk, the patients were retransfused to return the hemoglobin to greater than 7 g/dl. In addition, anesthesia-induced reduction in brain oxygen consumption could have also protected the brain from such ill effects.46,47 Finally, our results may not be applicable to patients with abnormal hemoglobin and patients with hypovolemia or shock.48 Moreover, the high partial pressure of oxygen due to high inspired oxygen concentration could have also influenced our results.49 
The indocyanine green infusion technique is limited by assessing only total splanchnic blood flow rather than the distribution of flow between the liver and gut.19,20 In abdominal surgery group, only portal blood flow was measured during surgery. Therefore, we could not compare splanchnic vascular bed responses between abdominal surgery and spine groups during ANA. However Do2and oxygen consumption responses during ANA were similar in both groups. Finally, the sample size of our abdominal surgery group (preportal group) was small. However, this reflects the relative inaccessibility of this vascular bed for hemodynamic studies. Nevertheless, this is the first study that provides quantitative data for splanchnic and preportal oxygen utilization during ANA.
In conclusion, acute reduction of hemoglobin concentration to 5.9 ± 0.3 g/dl in anesthetized humans by ANA sufficiently diminished splanchnic and preportal Do2such that oxygen consumption became impaired, although systemic oxygenation apparently remained adequate. Inadequate splanchnic oxygenation was also supported by the demonstration of increased regional lactate generation and increased plasma ratios of βOHB/AcAc sampled from the hepatic vein. Our findings demonstrate that the gastrointestinal tract has limited tolerance for ANA.
The authors thank Christi Perry (Assistant to Mali Mathru, M.D., Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas) and Maria D. Shaffer (Assistant to Mali Mathru, M.D., Department of Anesthesiology, University of Alabama at Birmingham, Birmingham, Alabama) for the preparation of the manuscript; and JoAnn Aaron and Jordan Kicklighter (Editorial Staff, Department of Anesthesiology, University of Texas Medical Brach) for their editorial assistance before submission. The authors also thank Timothy Ness, M.D., Ph.D. (Professor), and John D. Lang, Jr., M.D. (Associate Professor), both of the Department of Anesthesiology, University of Alabama at Birmingham, for their stimulating discussions and helpful comments.
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusions Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409–17Hebert, PC Wells, G Blajchman, MA Marshall, J Martin, C Pagliarello, G Tweeddale, M Schweitzer, I Yetisir, E
Messmer KF: Acceptable hematocrit levels in surgical patients. World J Surg 1987; 11:41–6Messmer, KF
Glick YA, Wilson LD, Aiello J: Hematocrit and metabolic changes caused by varied resuscitation strategies in a canine model of hemorrhagic shock. Am J Emerg Med 2002; 20:303–9Glick, YA Wilson, LD Aiello, J
Mathru M, Kleinman B, Blakeman B, Dries D, Zecca A, Rao T: Cardiovascular adjustments and gas exchange during extreme hemodilution in humans. Crit Care Med 1991; 19:700–4Mathru, M Kleinman, B Blakeman, B Dries, D Zecca, A Rao, T
Chapler CK, Cain SM: The physiologic reserve in oxygen carrying capacity: Studies in experimental hemodilution. Can J Physiol Pharmacol 1986; 64:7–12Chapler, CK Cain, SM
Levine E, Rosen A, Sehgal L, Gould S, Sehgal H, Moss G: Physiologic effects of acute anemia: implications for a reduced transfusion trigger. Transfusion 1990; 30:11–4Levine, E Rosen, A Sehgal, L Gould, S Sehgal, H Moss, G
Cain SM: Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol 1977; 42:228–34Cain, SM
Schumacker PT, Cain SM: The concept of a critical oxygen delivery. Intensive Care Med 1987; 13:223–9Schumacker, PT Cain, SM
Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA: Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217–21Weiskopf, RB Viele, MK Feiner, J Kelley, S Lieberman, J Noorani, M Leung, JM Fisher, DM Murray, WR Toy, P Moore, MA
Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, Toy P, Viele M: Critical oxygen delivery in conscious humans is less than 7.3 ml O2· kg−1· min−1. Anesthesiology 2000; 92:407–13Lieberman, JA Weiskopf, RB Kelley, SD Feiner, J Noorani, M Leung, J Toy, P Viele, M
van Woerkens EC, Trouwborst A, van Lanschot JJ: Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992; 75:818–21van Woerkens, EC Trouwborst, A van Lanschot, JJ
Race D, Dedichen H, Schenk WG: Regional blood flow during dextran-induced normovolemic hemodilution in the dog. J Thorac Cardiovasc Surg 1967; 53:578–86Race, D Dedichen, H Schenk, WG
Siegemund M, Van Bommel J, Ince C: Assessment of regional tissue oxygenation. Intensive Care Med 1999; 25:1044–60Siegemund, M Van Bommel, J Ince, C
Fan FC, Chen RY, Schuessler GB, Chien S: Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J Physiol 1980; 238:H545–622Fan, FC Chen, RY Schuessler, GB Chien, S
Schwarte LA, Fournell A, van Bommel J, Ince C: Redistribution of intestinal microcirculatory oxygenation during acute hemodilution in pigs. J App Physiol 2005; 98:1070–5Schwarte, LA Fournell, A van Bommel, J Ince, C
Gelman S: General anesthesia and hepatic circulation. Can J Physiol Pharmacol 1987; 65:1762–79Gelman, S
Van der Linden P, Gilbart E, Engelman E, Schmartz D, Vincent JL: Effects of anesthetic agents on systemic critical O2delivery. J Appl Physiol 1991; 71:83–93Van der Linden, P Gilbart, E Engelman, E Schmartz, D Vincent, JL
Weiskopf RB: Do we know when to transfuse red cells to treat acute anemia? Transfusion 1998; 38:517–21Weiskopf, RB
Bradley SE, Ingelfinger FJ, Bradley GP, Curry JJ: The estimation of hepatic blood flow in man. J Clin Invest 1945; 24:890–7Bradley, SE Ingelfinger, FJ Bradley, GP Curry, JJ
Uusaro A, Ruokonen E, Takala J: Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 1995; 30:106–12Uusaro, A Ruokonen, E Takala, J
Gross JB: Estimating allowable blood loss: Corrected for dilution. Anesthesiology 1983; 58:277–80Gross, JB
Payden JF, Vuillez JP, Geoffray B, Lafond JL, Comet M, Stieglitz P, Jacquot C: Effects of preoperative intentional hemodilution on the extravasation rate of albumin and fluid. Crit Care Med 1997; 25:243–8Payden, JF Vuillez, JP Geoffray, B Lafond, JL Comet, M Stieglitz, P Jacquot, C
Moreno LF, Stratton HH, Newell JC, Feustel PJ: Mathematical coupling of data: Correction of a common error for linear calculations. J App Physiol 1986; 60:335–43Moreno, LF Stratton, HH Newell, JC Feustel, PJ
Chinkes DL, Zhang XJ, Romijn JA, Sakurai Y, Wolfe RR: Measurement of pyruvate and lactate kinetics across the hindlimb and gut of anesthetized dogs. Am J Physiol 1994; 267:E174–82Chinkes, DL Zhang, XJ Romijn, JA Sakurai, Y Wolfe, RR
Dodds WJ: The pig model for biomedical research. Fed Proc 1982; 41:247–56Dodds, WJ
Noldge GF, Priebe HJ, Geiger K: Splanchnic hemodynamics and oxygen supply during acute normovolemic hemodilution alone and with isoflurane-induced hypotension in the anesthetized pig. Anesth Analg 1992; 75:660–74Noldge, GF Priebe, HJ Geiger, K
Noldge GF, Priebe HJ, Bohle W, Buttler KJ, Geiger K: Effects of acute normovolemic hemodilution on splanchnic oxygenation and on hepatic histology and metabolism in anesthetized pigs. Anesthesiology 1991; 74:908–18Noldge, GF Priebe, HJ Bohle, W Buttler, KJ Geiger, K
Haisjackl M, Luz G, Sparr H, Germann R, Salak N, Friesenecker B, Deusch E, Meusburger S, Hasibeder W: The effects of progressive anemia on jejunal mucosal and serosal tissue oxygenation in pigs. Anesth Analg 1997; 84:538–44Haisjackl, M Luz, G Sparr, H Germann, R Salak, N Friesenecker, B Deusch, E Meusburger, S Hasibeder, W
van Bommel J, Trouwborst A, Schwarte L, Siegemund M, Ince C, Henny ChP: Intestinal and cerebral oxygenation during severe isovolemic hemodilution and subsequent hyperoxic ventilation in a pig model. Anesthesiology 2002; 97: 660–70van Bommel, J Trouwborst, A Schwarte, L Siegemund, M Ince, C Henny, ChP
Lee SS, Hadengue A, Girod C, Braillon A, Lebrec D: Divergent circulatory effects of betaxolol in conscious and anesthetized normal and portal hypertensive rats. J Hepatol 1991; 12:157–61Lee, SS Hadengue, A Girod, C Braillon, A Lebrec, D
Charbon GA, Reneman RS: The effects of β-receptor agonists and antagonists on regional blood flow. Eur J Pharmacol 1970; 9:21–6Charbon, GA Reneman, RS
Westaby D, Bihari DJ, Gimson AE, Crossley IR, Williams R: Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut 1984; 25:121–4Westaby, D Bihari, DJ Gimson, AE Crossley, IR Williams, R
Schlictig R, Klions HA, Kramer DJ, Nemoto EM: Hepatic dysoxia commences during O2supply dependence. J Appl Physiol 1992; 72:1499–1505Schlictig, R Klions, HA Kramer, DJ Nemoto, EM
Dishart MK, Schlichtig R, Tonnessen TI, Rozenfeld RA, Simplaceanu E, Williams D, Gayowski TJ: Mitochondrial redox state as a potential detector of liver dysoxia in vivo  . J Appl Physiol 1998; 84:791–7Dishart, MK Schlichtig, R Tonnessen, TI Rozenfeld, RA Simplaceanu, E Williams, D Gayowski, TJ
Gore DC, Jahoor F, Hibbert JM, DeMaria EJ: Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 224:97–102Gore, DC Jahoor, F Hibbert, JM DeMaria, EJ
Youn JH, Bergman RN: Conversion of oral glucose to lactate in dogs: Primary site and relative contribution to blood lactate. Diabetes 1991; 40:738–47Youn, JH Bergman, RN
Nelson DP, Beyer C, Samsel RW, Wood LD, Schumacker PT: Pathological supply dependence of O2uptake during bacteremia in dogs. J Appl Physiol 1987; 63:1487–92Nelson, DP Beyer, C Samsel, RW Wood, LD Schumacker, PT
Ickx BE, Rigolet M, Van der Linden PJ: Cardiovascular and metabolic response to acute normovolemic anemia: Effects of anesthesia. Anesthesiology 2000; 93:1011–6Ickx, BE Rigolet, M Van der Linden, PJ
Poli de Figueiredo LF, Mathru M, Tao W, Solanki D, Uchida T, Kramer GC: Hemodynamic effects of isovolemic hemodilution during descending thoracic aortic cross clamping and lower torso reperfusion. Surgery 1997; 122:32–8Poli de Figueiredo, LF Mathru, M Tao, W Solanki, D Uchida, T Kramer, GC
Theye RA, Tuohy GF: Oxygen uptake during light halothane anesthesia in man. Anesthesiology 1964; 25:627–33Theye, RA Tuohy, GF
Viale JP, Annat G, Bertrand O, Thouverez B, Hoen JP, Motin J: Continuous measurement of pulmonary gas exchange during general anaesthesia in man. Acta Anaesthesiol Scand 1988; 32:691–7Viale, JP Annat, G Bertrand, O Thouverez, B Hoen, JP Motin, J
Van der Linden P, De Hert S, Mathieu N, Degroote F, Schmartz D, Zhang H, Vincent JL: Tolerance to acute isovolemic hemodilution: Effect of anesthetic depth. Anesthesiology 2003; 99:97–104Van der Linden, P De Hert, S Mathieu, N Degroote, F Schmartz, D Zhang, H Vincent, JL
Spahn DR, Seifert B, Pasch T, Schmid ER: Effects of chronic β-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease. Br J Anaesth 1997; 78:381–5Spahn, DR Seifert, B Pasch, T Schmid, ER
Hanique G, Dugernier T, Laterre PF, Dougnac A, Roeseler J, Reynaert MS: Significance of pathologic oxygen supply dependency in critically ill patients: Comparison between measured and calculated methods. Intensive Care Med 1994; 20:12–8Hanique, G Dugernier, T Laterre, PF Dougnac, A Roeseler, J Reynaert, MS
Weiskopf RB, Kramer JH, Viele M, Neumann M, Feiner JR, Watson JJ, Hopf HW, Toy P: Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92:1646–52Weiskopf, RB Kramer, JH Viele, M Neumann, M Feiner, JR Watson, JJ Hopf, HW Toy, P
Hoffman WE, Edelman G: Enhancement of brain tissue oxygenation during high dose isoflurane anesthesia in the dog. J Neurosurg Anesthesiol 2000; 12:95–8Hoffman, WE Edelman, G
Algotsson L, Messeter K, Nordstrom CH, Ryding E: Cerebral blood flow and oxygen consumption during isoflurane and halothane anesthesia in man. Acta Anaesthesiol Scand 1988; 32:15–20Algotsson, L Messeter, K Nordstrom, CH Ryding, E
Firth PG, Head CA: Sickle cell disease and anesthesia. Anesthesiology 2004; 101:766–85Firth, PG Head, CA
Meier J, Kemming GI, Kisch-Wedel H, Wolkhammer S, Habler OP: Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology 2004; 100:70–6Meier, J Kemming, GI Kisch-Wedel, H Wolkhammer, S Habler, OP
Table 1. Patient Characteristics 
Image not available
Table 1. Patient Characteristics 
Table 2. Systemic Response of ANA in Spine (n = 12) and Abdominal (n = 7) Surgery Groups of Patients 
Image not available
Table 2. Systemic Response of ANA in Spine (n = 12) and Abdominal (n = 7) Surgery Groups of Patients 
Table 3. Hepatosplanchnic and Preportal Flow, Do2, and O2ER in Patients Undergoing Spine and Abdominal Surgery 
Image not available
Table 3. Hepatosplanchnic and Preportal Flow, Do2, and O2ER in Patients Undergoing Spine and Abdominal Surgery 
Table 4. Biochemical Markers of Anaerobic Metabolism in Hepatosplanchnic Vascular Bed Spine Surgery Patients (n = 12) 
Image not available
Table 4. Biochemical Markers of Anaerobic Metabolism in Hepatosplanchnic Vascular Bed Spine Surgery Patients (n = 12)